UroFocus

Luigi Formisano, Patrizia Giannatempo e Roberto Iacovelli ci conducono tra le novità più importanti nel trattamento dei tumori genito-urinari.

[Roberto Iacovelli @DrIacovelli]

The 2nd UroOncoJourney in Rome 🇮🇹, was a great success! More than 140 participants, great speakers and a recognized place to discuss 1y of news in GU cancers! Special thank to @cvulsteke and to @cosimodenunzio @Albert0Briganti @BovePierluigi @GiuliaMarvaso84 @PasRescigno @alongi_filippo @SciarraUrology @AndreaTubaro @LuigiFormisano_ @ciccarese_c @GFornarini @RoccoPapaliaUro @MariaChiaraMCS @Sebastiano_Buti @giannatempopatr and many others. See you next year! @OncoAlert @oncodaily @OncoDailyGU @urofocus

[Umberto Malapelle @UmbertoMalapel1]

Incredibly honored to be appointed Adjunct Professor at @OhioStateMed College of Medicine. 
Thanks to @ChristianRolfo, the entire @OhioStateMedOnc team, my mentor Prof. Troncone, my group, and @UniNaofficial for the support.
@isliquidbiopsy @pmmpitalia

[Patrizia Giannatempo @giannatempopatr]

Many thanks to #ASCO, @nabiladra, @DrDarrenFeldman @siadaneshman for this excellent session: lively discussion, great energy, and many inspiring insights to bring home. #ASCO26 @oncodaily @Oncoinfo_it @TestesCancer

[UroFocus @urofocus]

Lo studio Lirespark-022 ha confrontato Belzutifan+Pembro vs Placebo+Pembro in pts con RCC operato ad elevato rischio di recidiva. Ne abbiamo parlato con @fmassari79 .
Ascolta la puntata su https://t.co/rc9wVxn27q

[UroFocus @urofocus]

Poche neoplasie stanno subendo un mutamento come il k vescicale specie nella sua fase localizzata muscolo infiltrante.
Quale neoadiuvante? Serve ancora la cistectomia?
Ne parliamo con Dr Calabro'.👇
https://t.co/OYomHrFGJv

[Tom Powles @tompowles1]

Discussion #EAU26 about the future of cystectomy neoadjuvant treatment and radiotherapy in muscle invasive bladder cancer. Things are changing rapidly. With pCR rates >50% for EVP many patients will want to keep their bladders. An era of ‘EVP 1st and ask questions later’ maybe a reality soon. Generation of EVP bladder sparing data is a priority. @Uroweb @EUplatinum

[UroFocus @urofocus]

Sei curioso di sapere quali sono state le novità su #RCC presentate a #GU26? Non perdere la puntata e vai sul link qui sotto...
https://t.co/SKDdgZ5Dpv
Urofocus ti da appuntamento per ulteriori approfondimenti nelle prossime settimane.

[UroFocus @urofocus]

Importanti novità nel trattamento del tumore vescicale nella giornata 2 di #GU26. Non perdere l'aggiornamento e i commenti del nostro team! Vai al link... https://t.co/Bb8LHy06nh

[Patrizia Giannatempo @giannatempopatr]

A truly beautiful moment of growth ❤️

[Patrizia Giannatempo @giannatempopatr]

🎙️ New episode of UroFocus is out.
We’re talking about burnout — honestly, openly, no filters.
🎧 Listen here:
https://t.co/80cYDOR8cw @LuigiFormisano_ @DrIacovelli @AssPalinuro @Oncoinfo_it @oncodaily

[Patrizia Giannatempo @giannatempopatr]

> 🎙️ New episode of #UroFocus! Fresh highlights from #ESMO25 on bladder cancer 🧬🔍
Emerging data, evolving treatments, and what’s next in the field.
▶️ Listen here: https://t.co/i9k0N8XZDX @DrIacovelli @LuigiFormisano_ @urofocus @oncodaily @AssPalinuro @Oncoinfo_it

[UroFocus @urofocus]

📢È stato un #ESMO25 entusiasmante per il #tumoredellavescica con 3️⃣ studi in sessione presidenziale ‼️
Non perderti l'aggiornamento di @urofocus e ascoltaci qui 👉🏻 https://t.co/1GxVkOX0nY @SIU_Italia @siuroIT @giannatempopatr @LuigiFormisano_ @DrIacovelli

[Patrizia Giannatempo @giannatempopatr]

#UroFocus is back with the hottest updates from #BladderDay #ESMO25!
💡 NMIBC: new approaches
🎯 mUC: strategic deintensification
🧬 Adjuvant therapy
Don’t miss it👉 https://t.co/IsNYqMNG1A @oncodaily @Oncoinfo_it @myESMO @DrIacovelli @LuigiFormisano_ @fmassari79 @vmollica7

[UroFocus @urofocus]

Sei curioso come noi di sapere cosa è successo nella giornata 1️⃣ di #ESMO25 ❓️Non perderti l'ultima puntata di @urofocus con degli ospiti d'eccezione! Vai a▶️ https://t.co/sQ7pZSjDTz Grazie a @fmassari79 @vmollica7 @Ric_Campi @siuroIT @SIU_Italia @AIOMtweet

[Umberto Malapelle @UmbertoMalapel1]

Great start of #ESMO25 by @myESMO President and the Scientific co - chairs @DrChoueiri and @MyriamChalabi!!
A pawerful #vision on the future of Oncology as a multidisciplinary community!

[Roberto Iacovelli @DrIacovelli]

POTOMAC trial introduces a new standard in #NMIBC showing significant EFS increase waiting for OS at #ESMO25. @myESMO @OncoAlert @GUOncologyNow @EAU_Uroonco

[Sarah Scagliarini, MD @SScagliarini_]

#Esmo25 - 🇩🇪 Berlin
Mini Oral Session - Renal and Bladder cancer
➡️ Full Hall 5.2!
⏩️Overfull Overflow too!!
This is the last headset available....✌🏼
As Always Fantastic Discussion @shilpaonc 👏🏼 @myESMO

[UroFocus @urofocus]

Le ultime news da Chicago sul #tumoredelrene con i commenti dei nostri esperti @SScagliarini_ @fmassari79 @Sebastiano_Buti. Non perdere l'ultima puntata e vai su #Spotify 👉🏻https://t.co/LUt5HsTRmy @SIU_Italia @siuroIT @uronauti @AntureIT @giannatempopatr @LuigiFormisano_

[Enrique Grande @drenriquegrande]

Things that only can happen at #guardsymposium2025, to be seated nearby the greatest @DrIacovelli before @PBarataMD starts his brilliant talk about how we should treat mRCC patients after adjuvant ICI-based treatment. I can’t wait to the discussion!!!! @GuardConsortium @OncoAlert @OncBrothers @_SEOM

[Sarah Scagliarini, MD @SScagliarini_]

#UroOncoJourney2025 🇮🇹
The multidisciplinary debate on #RCC is always heated 🔥 even more so if the best ( @CPRT65,@CiroFranzese1, Andrea Minervini) take the field, expertly arbitrated by @DrIacovelli. However, the goal can only be achieved together!! 🥅 @urofocus @AntureIT